Form D · Private Equity Fund

Hamilton Square Biotech Partners, LP

Princeton, NJ · CIK 0002069759

Offering snapshot reported Nov 13, 2025 · SEC filing

Reported sold
$510K
Indefinite offering
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 14, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported investors0 → 1

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 13, 2025Amendment$510,000No comparison1SEC filing
Jun 3, 2025InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-547925

Source: Form D, filed Nov 13, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

HAMILTON SQUARE BIOTECH PARTNERS, LP

Investment adviser: HAMILTON SQUARE PARTNERS MANAGEMENT, LP

Gross asset value
$24.1M
Beneficial owners
8
ADV minimum commitment
$1M

Reported in Form ADV on Sep 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator MORGAN STANLEY FUND SERVICES USA LLC PURCHASE, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor ERNST & YOUNG LLP NEW YORK, New York, United States
Custodian THE NORTHERN TRUST BANKING CORPORATION JERSEY CITY, New Jersey, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

ERNST & YOUNG LLP
PCAOB 42

THE NORTHERN TRUST BANKING CORPORATION
LEI 54930042DBMRRWU1QM80

Filing source

Form ADV 2135417 · Sep 30, 2026 · Schedule D 7.B.(1), fund 805-6639356856

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Hamilton Square Biotech Partners Gp, Llc Executive
Hamilton Square Partners Management, Lp Executive
David Tukey Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
300 Carnegie Center Suite 150
Princeton, NJ, 08540